Cart
sales@molnova.com
TAPI-1 trifluoroacetate
CAS No. ——
TAPI-1 trifluoroacetate ( —— )
Catalog No. M17699 CAS No. ——
TAPI-1 is an ADAM17/TACE inhibitor, which blocks shedding of cytokine receptors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 580 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTAPI-1 trifluoroacetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionTAPI-1 is an ADAM17/TACE inhibitor, which blocks shedding of cytokine receptors.
-
DescriptionTAPI-1 is an ADAM17/TACE inhibitor, which blocks shedding of cytokine receptors.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayNeuroscience
-
TargetP2 Receptor
-
RecptorADAM17/TACE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight613.62
-
Molecular FormulaC28H38F3N5O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(N[C@@H](C)C(NCCN)=O)[C@@H](NC(C(CC(NO)=O)CC(C)C)=O)CC1=CC2=CC=CC=C2C=C1.FC(F)(C(O)=O)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Müllberg J, et al. J Immunol. 1995, 155(11), 5198-5205
molnova catalog
related products
-
Diquafosol tetrasodi...
Diquafosol Tetrasodium is a P2Y2 receptor agonist that stimulates the secretion of mucins from ocular tissues Diquafosol tetrasodium improves tear film stability and visual function?as a topical treatment of dry eye disease.
-
Prasugrel
Prasugrel, a thienopyridine derivative, is a platelet activation and aggregation inhibitor structurally and pharmacologically related to clopidogrel and ticlopidine.
-
1,3-Bis(4-aminopheny...
1, 3-Bis(4-aminophenyl)urea can be used for screening of ALR inhibitors by detection of hydrogen peroxide production Measured in Biochemical System.
